Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/15/2005WO2005118820A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118819A1 Generation of plants with altered oil content
12/15/2005WO2005118818A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118817A1 Method for high speed screening for the identification of molecules inhibiting the activity of editing enzymes
12/15/2005WO2005118816A2 Protein exhibiting triglyceride hydrolase activity
12/15/2005WO2005118815A1 Polypeptides having dna polymerase activity
12/15/2005WO2005118814A2 Metabolically engineered cells for the production of polyunsaturated fatty acids
12/15/2005WO2005118813A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005WO2005118812A1 Method of producing astaxanthin or metabolic product thereof by using carotenoid ketolase and carotenoid hydroxylase genes
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118810A1 Agents and methods for diagnosing stress
12/15/2005WO2005118809A2 Methods and compositions for enhancing cell adhesion properties
12/15/2005WO2005118808A1 Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof
12/15/2005WO2005118807A1 Process for creating a double-stranded polyribonucleotide sequence with terminal overhang, as well as a process for creating a double-stranded polynucleotide construct and an application
12/15/2005WO2005118806A2 METHODS AND COMPOSITIONS INVOLVING MicroRNA
12/15/2005WO2005118805A1 Materials and methods for providing resistance to plant pathogens in non-transgenic plant tissue
12/15/2005WO2005118804A1 Method of specifically detecting bacterium belonging to the genus alicyclobacillus
12/15/2005WO2005118803A1 Container for nucleic acid extraction, method of cleaning solid matrix and relevant cleaning mechanism, and method of purifying nucleic acid
12/15/2005WO2005118802A2 Targeting pseudotyped retroviral vectors
12/15/2005WO2005118797A2 Biosynthetic gene cluster for tautomycetin
12/15/2005WO2005118790A2 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
12/15/2005WO2005118772A1 Container for nucleic acid amplification, nucleic acid preparation kit and nucleic acid analyzer
12/15/2005WO2005118647A2 M13 virus major coat protein variants for c-terminal and bi-terminal display of a heterologous protein
12/15/2005WO2005118631A1 Novel protein complex and use thereof
12/15/2005WO2005118629A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
12/15/2005WO2005118628A2 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use
12/15/2005WO2005118624A1 Peptides antagonists for inhibiting heat shock protein (hsp 16.3) of mycobacterium tuberculosis
12/15/2005WO2005117996A2 Immune response assessment method
12/15/2005WO2005117994A2 Bmp pathway methods and compositions
12/15/2005WO2005117993A2 Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer
12/15/2005WO2005117991A2 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
12/15/2005WO2005117989A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance
12/15/2005WO2005117975A2 Methods for treating vascular disease
12/15/2005WO2005117974A2 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005WO2005117950A2 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
12/15/2005WO2005117947A1 Use of the foamy virus bet protein for inactivating apobec
12/15/2005WO2005117938A2 Methods of treating ocular conditions
12/15/2005WO2005117897A2 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005WO2005117832A1 Liposomal assembly for therapeutic and/or diagnostic use
12/15/2005WO2005117577A2 Model for neurodegenerative disorders
12/15/2005WO2005117569A2 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom
12/15/2005WO2005117568A1 Plants having improved growth characteristics and a method for making the same
12/15/2005WO2005117557A2 Expression system
12/15/2005WO2005103263B1 Bone delivery conjugates and method of using same to target proteins to bone
12/15/2005WO2005098046A3 Methods for the determination of cell specific biomarkers
12/15/2005WO2005090570A9 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005WO2005085440A8 Method for enriching and/or separating prokaryotic dna using a protein that specifically bonds to unmethylated dna containing cpg-motives
12/15/2005WO2005083092A3 Transposon from aspergillus fumatigus and mutagenesis therewith
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005WO2005063976A3 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
12/15/2005WO2005062767A3 Hoxd3, hoxa3, and hoxb3 compositions and methods for improved wound healing
12/15/2005WO2005054485A3 Adenovirus-transfected primary cells and methods of pathway mapping
12/15/2005WO2005054466A3 Methods and compositions for preparing rna from a fixed sample
12/15/2005WO2005051423A3 Methods and agents for immune modulation and methods for identifying immune modulators
12/15/2005WO2005048914A3 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
12/15/2005WO2005046565A3 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases
12/15/2005WO2005046564A3 Diagnosis and treatment of liver fibrosis
12/15/2005WO2005044091A3 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
12/15/2005WO2005012359A3 Anti-vegf antibodies
12/15/2005WO2005007832A3 System for external control of oncolytic virus replication
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2004104162A3 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
12/15/2005WO2004096994A3 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
12/15/2005WO2004089072A9 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene
12/15/2005WO2004064737A3 Therapeutics compositions
12/15/2005WO2004053104A3 5’ cpg nucleic acids and methods of use
12/15/2005WO2004048511A3 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
12/15/2005WO2004000102A3 Method for predicting response to epidermal growth factor receptor-directed therapy
12/15/2005WO2003104405A3 Methods for promoting homologous recombination
12/15/2005WO2003087324A3 Antibody gene transfer and recombinant aav
12/15/2005WO2003062370A3 Multimeric proteins and methods of making and using same
12/15/2005WO2003029409A3 Methods for generating, selecting, and identifying compounds which bind a target molecule
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050278811 Inbred corn line PHC5H
12/15/2005US20050278809 Regulation of gene expression using chromatin remodelling factors
12/15/2005US20050278808 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production
12/15/2005US20050278807 Plant raffinose saccharide biosynthetic enzymes
12/15/2005US20050278806 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
12/15/2005US20050278805 Method of increasing seed oil content in plants
12/15/2005US20050278804 Methods for coupling resistance alleles in tomato
12/15/2005US20050278803 Compositions and methods for altering the disulfide status of proteins
12/15/2005US20050278802 Methods for tissue culturing and transforming elite inbreds of Zea mays L.
12/15/2005US20050278801 Plastid transit peptides
12/15/2005US20050278800 Compositions and methods for the modification of gene expression
12/15/2005US20050278799 Stress-induced promoter derived from rice
12/15/2005US20050278797 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals
12/15/2005US20050278796 FIAT nucleic acids and proteins and uses thereof
12/15/2005US20050278795 Stearoyl-CoA desaturase 4 gene
12/15/2005US20050277767 Novel human nuclear transporters and polynucleotides encoding the same
12/15/2005US20050277766 Udp-glucose aglycon-glucosytransferase
12/15/2005US20050277763 For cancer therapy
12/15/2005US20050277761 Potassium channel interactors polypeptides and uses thereof
12/15/2005US20050277618 Methods
12/15/2005US20050277613 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
12/15/2005US20050277612 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/15/2005US20050277610 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277608 Prevent, inhibit, or reduce hair growth, for hair removal or depilation; alopecia and atrichia
12/15/2005US20050277605 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
1 ... 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 ... 4023